NCT00386204

Brief Summary

The purpose of this study is a comparison of efficacy and side effects of Q-switched Ruby laser treatment for solar lentigines in two different skin types II and IV.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Nov 2005

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2005

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2006

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

October 10, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 11, 2006

Completed
Last Updated

June 4, 2008

Status Verified

June 1, 2008

First QC Date

October 10, 2006

Last Update Submit

June 2, 2008

Conditions

Solar Lentigines

Keywords

Q-switched Ruby laser

Outcome Measures

Primary Outcomes (2)

  • Clinical Clearance

  • Side Effects

Interventions

Q-switched Ruby LaserDEVICE

Eligibility Criteria

AgeUp to 80 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Solar Lentigines
  • Fitzpatrick skin type II and IV

You may not qualify if:

  • Pregnancy
  • Age above 80
  • Photosensitivity
  • Concern for malignancy
  • Active Infection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Skin Research Center, Shohada-e Tajrish Hospital, Shaheed Beheshti Medical University

Tehran, Tehran Province, 19899, Iran

Location

Study Officials

  • Parviz Toossi, M.D.

    Shahid Beheshti University of Medical Sciences

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

October 10, 2006

First Posted

October 11, 2006

Study Start

November 1, 2005

Study Completion

September 1, 2006

Last Updated

June 4, 2008

Record last verified: 2008-06

Locations

IR(1)